发布求助
文献互助 智能选刊 最新文献

European journal of respiratory diseases最新文献

筛选
英文 中文
Regression of a malignant tumour of the pleura. 胸膜恶性肿瘤的消退。
European journal of respiratory diseases Pub Date : 1987-08-01
F Maesen, R Willighagen
{"title":"Regression of a malignant tumour of the pleura.","authors":"F Maesen, R Willighagen","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":12053,"journal":{"name":"European journal of respiratory diseases","volume":"71 2","pages":"135-8"},"PeriodicalIF":0.0,"publicationDate":"1987-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14742610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortality related to smoking habits, respiratory symptoms and lung function. 死亡率与吸烟习惯、呼吸道症状和肺功能有关。
European journal of respiratory diseases Pub Date : 1987-08-01
J Olofson, B E Skoogh, B Bake, K Svärdsudd
{"title":"Mortality related to smoking habits, respiratory symptoms and lung function.","authors":"J Olofson,&nbsp;B E Skoogh,&nbsp;B Bake,&nbsp;K Svärdsudd","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The relationship between smoking habits, respiratory symptoms and lung function at the start of the study and mortality during a follow-up period of 11 years was studied in 607 men, aged 50 and 60 years at entry and sampled from the general population. The overall mortality rate in the sample was 18%. In a logistic multiple regression model, mortality rate was significantly related to age, smoking habits, dyspnea and one of the lung function variables FEV1, VC or the slope of phase III. Smokers had a double mortality rate compared to non-smokers (22 versus 10%) after allowing for age, dyspnea and lung function. Similarly, in subjects with abnormal FEV1, VC or slope of phase III, the mortality rate was almost doubled compared to subjects with normal lung function, other factors being equal. Thus, impaired lung function is an important factor to be considered in the assessment of mortality risk, besides smoking and dyspnea.</p>","PeriodicalId":12053,"journal":{"name":"European journal of respiratory diseases","volume":"71 2","pages":"69-76"},"PeriodicalIF":0.0,"publicationDate":"1987-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14742612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic cough as a risk indicator of broncho-pulmonary disease. 慢性咳嗽是支气管肺疾病的危险指标。
European journal of respiratory diseases Pub Date : 1987-08-01
H Puolijoki, A Lahdensuo
{"title":"Chronic cough as a risk indicator of broncho-pulmonary disease.","authors":"H Puolijoki,&nbsp;A Lahdensuo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The aim of this study was to discover the subsequent histories and ultimate diagnoses in 182 patients studied in a chest clinic because of unexplained cough. Twenty-nine patients (16%) developed asthma during the mean follow-up time of 4.4 years. Chronic bronchitis was diagnosed in 18 patients (10%) and sporadic instances of some other diseases were also seen. The development of asthma was studied both by calculating simple relative risks and using a multiple logistic model. Circadian changes in peak expiratory flow (PEF)-values and total blood eosinophil count were found to be the best variables for predicting the risk of developing asthma in a patient with unexplained cough, whereas mild bronchial hyperreactivity had only a low predictive value. If the risk of developing asthma in a patient presenting with unexplained cough is to be estimated, attention should be paid simultaneously to a number of variables. Even mild abnormalities in several variables can be significant when they occur together.</p>","PeriodicalId":12053,"journal":{"name":"European journal of respiratory diseases","volume":"71 2","pages":"77-85"},"PeriodicalIF":0.0,"publicationDate":"1987-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14743271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No influence of acetylcysteine on gas exchange and spirometry in chronic asthma. 乙酰半胱氨酸对慢性哮喘患者气体交换和肺活量测定无影响。
European journal of respiratory diseases Pub Date : 1987-08-01
G Bylin, G Hedenstierna, L Lagerstrand, P D Wagner
{"title":"No influence of acetylcysteine on gas exchange and spirometry in chronic asthma.","authors":"G Bylin,&nbsp;G Hedenstierna,&nbsp;L Lagerstrand,&nbsp;P D Wagner","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Non-smoking patients (n:25) with stable symptomatic asthma were investigated with regard to the pulmonary effects of N-acetylcysteine (NAC), peroral dose 200 mg three times daily, in a crossover double-blind study. They were studied once a week for 9 weeks, with a run-in period and periods with NAC and placebo (3 weeks each). Functional residual capacity and specific airway resistance were 19 and 53% larger, respectively, and forced expiratory variables (FEV%, MEF25) were 20 and 53% lower than reference values. Distribution of ventilation-perfusion ratios (VA/Q), assessed by multiple inert gas elimination technique with peripheral venous sampling, was abnormal, although arterial PO2 and PCO2 were within normal limits. NAC medication had no effect on any spirometric, lung mechanic or gas exchange variable, nor on the frequency of pulmonary symptoms.</p>","PeriodicalId":12053,"journal":{"name":"European journal of respiratory diseases","volume":"71 2","pages":"102-7"},"PeriodicalIF":0.0,"publicationDate":"1987-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14431614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autoantibodies in infections of the respiratory tract with Mycoplasma pneumoniae or influenza virus A. 呼吸道感染肺炎支原体或甲型流感病毒的自身抗体。
European journal of respiratory diseases Pub Date : 1987-08-01
M E Hodson, P Taylor
{"title":"Autoantibodies in infections of the respiratory tract with Mycoplasma pneumoniae or influenza virus A.","authors":"M E Hodson,&nbsp;P Taylor","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The sera from 26 patients with serological evidence of infection with Mycoplasma pneumoniae and 23 patients with influenza virus A infection were examined for autoantibodies to smooth muscle, cell nuclei and 'reticulin'. There is an increased incidence of autoantibodies to smooth muscle (46%) in the serum of patients infected with M. pneumoniae. There is no increase in autoantibodies to cell nuclei or 'reticulin' in these patients. There is no increased incidence of autoantibodies in patients infected with influenza virus A. The possible aetiology of the raised incidence of smooth muscle autoantibodies in the patients with M. pneumoniae is discussed.</p>","PeriodicalId":12053,"journal":{"name":"European journal of respiratory diseases","volume":"71 2","pages":"86-92"},"PeriodicalIF":0.0,"publicationDate":"1987-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14246146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IgG antibody level to mycobacterial glycoprotein in pulmonary tuberculosis by ELISA. ELISA检测结核分枝杆菌糖蛋白IgG抗体水平。
European journal of respiratory diseases Pub Date : 1987-07-01
K Kato, K Yamamoto, M Shibata, S Kurematsu, O Mitsuhashi, A Kuze
{"title":"IgG antibody level to mycobacterial glycoprotein in pulmonary tuberculosis by ELISA.","authors":"K Kato,&nbsp;K Yamamoto,&nbsp;M Shibata,&nbsp;S Kurematsu,&nbsp;O Mitsuhashi,&nbsp;A Kuze","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Sera from patients with active pulmonary tuberculosis and sera from appropriate control individuals were assayed for IgG, IgA and IgM antibodies against glycoprotein from tubercle bacilli by an enzyme-linked immunosorbent assay. The mean antibody levels in IgG and IgA were significantly higher in the tuberculosis patients than in the controls. By measuring IgG antibody, this assay may provide a diagnostic tool to distinguish patients with active pulmonary tuberculosis from patients with other pulmonary disease.</p>","PeriodicalId":12053,"journal":{"name":"European journal of respiratory diseases","volume":"71 1","pages":"37-41"},"PeriodicalIF":0.0,"publicationDate":"1987-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14247417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dose of inhaled budesonide required to produce clinical suppression of plasma cortisol. 吸入布地奈德对血浆皮质醇产生临床抑制所需的剂量。
European journal of respiratory diseases Pub Date : 1987-07-01
A C Gordon, C F McDonald, S A Thomson, M H Frame, A Pottage, G K Crompton
{"title":"Dose of inhaled budesonide required to produce clinical suppression of plasma cortisol.","authors":"A C Gordon,&nbsp;C F McDonald,&nbsp;S A Thomson,&nbsp;M H Frame,&nbsp;A Pottage,&nbsp;G K Crompton","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Increasing dose of budesonide, each dose given for a minimum of 1 month, were administered via a Nebuhaler to 14 patients. Two consecutive abnormally low fasting morning plasma cortisol values, taken 2 weeks apart, were accepted as evidence of hypothalamo-pituitary-adrenal (HPA) hypofunction. Data from nine of the 14 patients entering the study were available for analysis. One patient developed HPA hypofunction while inhaling 2.4 mg budesonide per day and another retained normal HPA function on a dose of 12 mg. In the remaining patients, intermediate doses resulted in suppression, or the patients were withdrawn unsuppressed for other reasons (n = 3). The results in this small patient sample suggest that budesonide administered via the Nebuhaler in doses up to 1.6 mg daily does not significantly affect plasma cortisol.</p>","PeriodicalId":12053,"journal":{"name":"European journal of respiratory diseases","volume":"71 1","pages":"10-4"},"PeriodicalIF":0.0,"publicationDate":"1987-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14773992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isoniazid and ethambutol as a cause of optic neuropathy. 异烟肼和乙胺丁醇是视神经病变的原因。
European journal of respiratory diseases Pub Date : 1987-07-01
V E Jimenez-Lucho, R del Busto, J Odel
{"title":"Isoniazid and ethambutol as a cause of optic neuropathy.","authors":"V E Jimenez-Lucho,&nbsp;R del Busto,&nbsp;J Odel","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A well-recognized complication of ethambutol use is optic neuropathy, but the potential ocular toxicity of isoniazid is often overlooked. A patient developed optic neuropathy while being treated with isoniazid and ethambutol. The optic neuropathy subsided only when both drugs were discontinued, suggesting an additive toxic effect.</p>","PeriodicalId":12053,"journal":{"name":"European journal of respiratory diseases","volume":"71 1","pages":"42-5"},"PeriodicalIF":0.0,"publicationDate":"1987-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14247418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapidly progressive interstitial lung disease in a hard metal coating worker undergoing hemodialysis. 进行血液透析的硬质金属涂层工人的快速进行性肺间质性疾病。
European journal of respiratory diseases Pub Date : 1987-07-01
T Rochat, R M Kaelin, A Batawi, A F Junod
{"title":"Rapidly progressive interstitial lung disease in a hard metal coating worker undergoing hemodialysis.","authors":"T Rochat,&nbsp;R M Kaelin,&nbsp;A Batawi,&nbsp;A F Junod","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":12053,"journal":{"name":"European journal of respiratory diseases","volume":"71 1","pages":"46-51"},"PeriodicalIF":0.0,"publicationDate":"1987-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14773996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyaluronate in bronchoalveolar lavage fluid in sarcoidosis and its relationship to alveolar cell populations. 结节病支气管肺泡灌洗液中的透明质酸及其与肺泡细胞群的关系。
European journal of respiratory diseases Pub Date : 1987-07-01
A Eklund, R Hällgren, E Blaschke, A Engström-Laurent, U Persson, B Svane
{"title":"Hyaluronate in bronchoalveolar lavage fluid in sarcoidosis and its relationship to alveolar cell populations.","authors":"A Eklund,&nbsp;R Hällgren,&nbsp;E Blaschke,&nbsp;A Engström-Laurent,&nbsp;U Persson,&nbsp;B Svane","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Hyaluronate is a potential marker of activated pulmonary fibroblasts and appears in increased amounts in bronchoalveolar lavage fluid from patients with sarcoidosis. This study was performed to investigate a possible link between the local immune response and pulmonary fibroblast proliferation. The median hyaluronate concentration in the lavage fluid from 23 sarcoid patients was 12.0 (interquartile range 7.5-28.5) micrograms/l. The hyaluronate concentration was positively correlated to the concentration and proportion of lymphocytes (p less than 0.001 and p less than 0.01, respectively) as well as to the concentrations of T lymphocyte subsets (OKT4+ p less than 0.01, OKT8+ p less than 0.05). No correlation was found between the hyaluronate concentration and the OKT4+/OKT8+ ratio. Furthermore, a significant correlation was observed in the lavage fluid between hyaluronate and angiotensin-converting enzyme, a marker of monocyte/macrophage activity (p less than 0.01). Thus, the intensity of the sarcoid alveolitis was associated with biochemical signs of pulmonary fibroblast proliferation/activation in sarcoidosis.</p>","PeriodicalId":12053,"journal":{"name":"European journal of respiratory diseases","volume":"71 1","pages":"30-6"},"PeriodicalIF":0.0,"publicationDate":"1987-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13958533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信